Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 2,788.07 | 613.33 | 444.35¢ | 32.1 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,198.83 | 860.96 | 648.74¢ | 22.0 | 0.5 | +46% | n/a | 0.0% |
31-Dec-27 | 3,572.97 | 1,124.85 | 832.08¢ | 17.2 | 0.6 | +28% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Also | 24-Jun-2006 | LA Times |
Also | 17-May-2006 | LA Times |
F.D.A. Demurs on Sleep Drug by Neurocrine | 17-May-2006 | New York Times |
Currency | US Dollars |
Share Price | $ 142.73 |
Change Today | $ 1.83 |
% Change | 1.30 % |
52 Week High | $143.39 |
52 Week Low | $141.18 |
Volume | 611,736 |
Shares Issued | 91.27m |
Market Cap | $13,026m |
RiskGrade | 225 |
Strong Buy | 11 |
Buy | 11 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 26 |
Time | Volume / Share Price |
16:00 | 107,019 @ $142.73 |
15:59 | 128 @ $142.71 |
15:59 | 100 @ $142.72 |
15:59 | 100 @ $142.72 |
15:59 | 100 @ $142.73 |
You are here: research